Related Experiment Videos
Combined therapy for inflammatory breast cancer
1Department of Surgery, Medical College of Wisconsin, Milwaukee.
Archives of Surgery (Chicago, Ill. : 1960)
|May 1, 1990
Summary
This review of inflammatory breast cancer management found that initial chemotherapy improved survival rates. However, the effectiveness of mastectomy versus irradiation for local control remains unclear.
Area of Science:
- Oncology
- Medical Management
Background:
- Inflammatory breast cancer (IBC) historically has a poor prognosis.
- Recent advancements suggest improved outcomes for IBC patients.
Purpose of the Study:
- To evaluate current management strategies for IBC.
- To identify prognostic factors influencing survival in IBC patients.
- To assess treatment outcomes at three Milwaukee hospitals between 1967 and 1987.
Main Methods:
- Retrospective review of 25 IBC patients diagnosed between 1967 and 1987.
- Analysis of treatment modalities including combination chemotherapy, radiation therapy, and mastectomy.
- Evaluation of survival rates based on treatment received and clinical factors.
Main Results:
- The 5-year survival rate for patients without initial distant metastases was 24%.
- Patients receiving chemotherapy before local treatment showed a 40% 5-year survival rate.
- Clinically involved axillary nodes or a palpable mass correlated with poorer survival; dermal lymphatic invasion did not significantly impact survival.
Conclusions:
- Initial chemotherapy is a crucial component in managing inflammatory breast cancer.
- The role of mastectomy versus irradiation in achieving local control and improving survival requires further investigation.